Similar articles

• Low-dose doxepin for the treatment of insomnia: emerging data.

  Goforth HW. Goforth HW. Expert Opin Pharmacother. 2009 Jul;10(10):1649-55. doi: 10.1517/14656560903005587. Expert Opin Pharmacother. 2009. PMID: 19496739 Review.
• Low-dose doxepin: in the treatment of insomnia.

  Weber J, Siddiqui MA, Wagstaff AJ, McCormack PL. Weber J, et al. CNS Drugs. 2010 Aug;24(8):713-20. doi: 10.2165/11200810-000000000-00000. CNS Drugs. 2010. PMID: 20658801 Review.
• Tricyclic antidepressant blood levels.

  Marshall ZT, Lippmann SB. Marshall ZT, et al. Am Fam Physician. 1988 Mar;37(3):251-4. Am Fam Physician. 1988. PMID: 3348124
• Nocturnal melatonin secretion and sleep after doxepin administration in chronic primary insomnia.

  Hajak G, Rodenbeck A, Adler L, Huether G, Bandelow B, Herrendorf G, Staedt J, Rüther E. Hajak G, et al. Pharmacopsychiatry. 1996 Sep;29(5):187-92. doi: 10.1055/s-2007-979569. Pharmacopsychiatry. 1996. PMID: 8895944 Clinical Trial.
• The jitteriness syndrome in panic disorder patients treated with antidepressants.

  Pohl R, Yeragani VK, Balon R, Lycaki H. Pohl R, et al. J Clin Psychiatry. 1988 Mar;49(3):100-4. J Clin Psychiatry. 1988. PMID: 3346196